Home   >  
∨

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Microbiology/Virology

Chemical Structure Cat. No. Product Name CAS No.
Pirlimycin hydrochloride Chemical Structure
 BCP31935 Pirlimycin hydrochloride 78822-40-9
Pirlimycin Hydrochloride is a semi-synthetic lincosaminide antibiotic. Pirlimycin Hydrochloride is a Clindamycin analog.
Pirlimycin Chemical Structure
 BCP31934 Pirlimycin 79548-73-5
Pirlimycin is a semi-synthetic lincosamide prepared from clindamycin by hydrolysing the propyl N-methylproline and re-annealing a 4-ethylpipecolic acid; a broad spectrum antibiotic with activity against anaerobic bacteria and protozoans by binding to the 23S ribosomal subunit, blocking protein synthesis
Sitafloxacin hydrate (2:3) Chemical Structure
 BCP31925 Sitafloxacin hydrate (2:3) 163253-35-8
Sitafloxacin Hydrate is a new-generation, broad-spectrum oral fluoroquinolone antibiotic.
Deglycosylation Avibactam Chemical Structure
 BCP31868 Deglycosylation Avibactam DA
Avibactam is a covalent, reversible non-β-lactam β-lactamase inhibitor, inhibits β-lactamase TEM-1 and CTX-M-15 with IC50 of 8 nM and 5 nM, respectively.
Methyl leucylleucinate hydrochloride Chemical Structure
 BCP31707 Methyl leucylleucinate hydrochloride 6491-83-4
L-Leucyl-L-Leucine methyl ester (LLME) is a lysosomal condensation product that has been reported to be cytotoxic towards natural killer cells and CD4 It has also been shown to induce death of monocytes, polymorphonuclear leukocytes, and myeloid tumor cells.
Quinupristin-Dalfopristin mixt Chemical Structure
 BCP30272 Quinupristin-Dalfopristin mixt 126602-89-9
Quinupristin-dalfopristin is a 70:30 (w/w) complex of two semi-synthetic analogues marketed as synercid; a highly effective antibiotic, including activity against resistant strains.
Clofazimine Chemical Structure
 BCP07792 Clofazimine 2030-63-9
Clofazimine is a fat-soluble iminophenazine dye, has a marked anti-inflammatory effect, has been used in combination with other antimycobacterial drugs to treat AIDS and Crohn's disease.
Pristinamycin IA Chemical Structure
 BCP31526 Pristinamycin IA 3131-03-1
Pristinamycin IA is a biologically active decapeptide isolated from the skin of the Australian frog Hyla caerulea, is a potent cholecystokinetic agent, and acts as a cholecystokinin receptor agonist.
Pristinamycin IIA Chemical Structure
 BCP31523 Pristinamycin IIA 21411-53-0
Pristinamycin IIA is a macrolide antibiotic, a member of the streptogramin A group of antibiotics, and one component of pristinamycin. It is produced by Streptomyces graminofaciens and other bacteria.
AX20017 Chemical Structure
 BCP31476 AX20017 329221-38-7
AX20017 is a small-molecule protein kinase G (PknG) inhibitor with an IC50 of 0.39 μM.
123下一页末页共 821 条记录 1 / 83 页 
0086-15971444841